Westchester, Philips to partner on precision medicine
Ten-facility Westchester Medical Center Health Network in Valhalla, N.Y., has launched a precision medicine initiative to improve cancer care enterprisewide across its acute and ambulatory facilities, and it has tapped Philips Healthcare as a core supporting vendor.
The delivery system will use Philips’ IntelliSpace Genomics product to combine genomic sequencing data with clinical data, including pathology, medical images, genomic databases and longitudinal patient records, and supported with health data exchange services to tailor treatment to a patient’s genomic makeup, and then develop therapy strategies at the point of care.
“Our precision medicine platform for oncology is designed to leverage all available sources of critical information to help make the most informed decisions about each patient’s care,” says John Fallon, MD, director of the department of clinical pathology at Westchester.
Westchester Medical Center has additional precision medicine initiatives in the works, such as the new cellular and tissue engineering laboratory that supports cellular therapy under investigational new drug applications covering hematological and oncological diseases.
The recently announced initiative follows the announcement last year that Royal Philips and Westchester Medical Center had launched a 15-year, $500 million partnership to transform and improve healthcare. The effort is using an enterprise managed services model through which Philips provides the organization with a range of clinical and business consulting services, as well as advanced medical technologies. The partners stated they were seeking to “redefine how quality care is delivered.”